TipRanks
Elevate Uranium Ltd (AU:EL8)
ASX:EL8
Want to see AU:EL8 full AI Analyst Report?

Elevate Uranium Ltd (EL8) AI Stock Analysis

28 Followers

Top Page

AU:EL8

Elevate Uranium Ltd

(Sydney:EL8)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - Gpt-5.6Sol)
Rating:45Neutral
Price Target:
AU$0.21
▼(-31.67% Downside)
Action:Reiterated
Date:09/26/26
The score is primarily held back by weak financial performance (negligible revenue, widening losses, and ongoing cash burn). Technicals also lean bearish with the price below major moving averages and a negative MACD. The main support comes from the strong, low-debt balance sheet, while valuation is hard to assess given negative earnings and no dividend yield.
Positive Factors
Low Leverage
Very low leverage reduces solvency pressure and limits interest-related demands on future cash flows. With assets largely funded by equity, Elevate retains greater financial flexibility to continue exploration and advance projects without the constraints of substantial debt obligations.
Negative Factors
Negligible Revenue
The absence of meaningful recurring revenue shows that Elevate remains pre-production and has not yet established an operating income base. This limits internal funding capacity and leaves future financial progress dependent on successful project advancement and eventual commercialisation.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Very low leverage reduces solvency pressure and limits interest-related demands on future cash flows. With assets largely funded by equity, Elevate retains greater financial flexibility to continue exploration and advance projects without the constraints of substantial debt obligations.
Read all positive factors

Elevate Uranium Ltd (EL8) vs. iShares MSCI Australia ETF (EWA)

Elevate Uranium Ltd Business Overview & Revenue Model

Company Description
Headquartered in West Perth, Australia, Elevate Uranium Ltd focuses on the exploration and evaluation of uranium reserves, a business it has pursued since its incorporation in 1978. The company's key operations are distributed across two main regi...
How the Company Makes Money
null...

Elevate Uranium Ltd Financial Statement Overview

Summary
Overall financial profile is weak due to an early-stage/pre-production model: revenue is negligible and volatile (A$0 in 2026 vs A$0.77m in 2025), losses are widening (EBIT -A$16.4m; net loss -A$15.4m in 2026), and cash burn remains heavy (operating cash flow -A$12.7m; free cash flow -A$13.3m in 2026). The main offsetting positive is a strong, low-debt balance sheet (debt ~A$0.32m vs equity A$35.3m).
Income Statement
14
Very Negative
Balance Sheet
72
Positive
Cash Flow
22
Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue0.00768.50K182.000.000.00
Gross Profit-272.97K768.50K-121.67K-117.68K-85.52K
EBITDA-16.15M-11.85M-10.62M-8.51M-5.68M
Net Income-15.44M-12.32M-10.75M-8.63M-5.73M
Balance Sheet
Total Assets37.32M25.46M13.26M12.54M19.33M
Cash, Cash Equivalents and Short-Term Investments28.82M21.71M10.83M10.06M15.81M
Total Debt322.22K432.41K74.21K146.03K177.27K
Total Liabilities2.22M1.57M1.48M1.02M838.59K
Stockholders Equity35.29M23.89M11.78M11.52M18.49M
Cash Flow
Free Cash Flow-13.30M-11.71M-9.31M-5.90M-4.49M
Operating Cash Flow-12.70M-11.62M-9.24M-5.83M-4.38M
Investing Cash Flow-3.35M-714.24K-73.79K-74.52K-137.62K
Financing Cash Flow23.13M23.22M10.09M158.86K13.67M

Elevate Uranium Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.30
Price Trends
50DMA
0.25
Negative
100DMA
0.25
Negative
200DMA
0.29
Negative
Market Momentum
MACD
-0.01
Positive
RSI
36.54
Neutral
STOCH
13.79
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:EL8, the sentiment is Negative. The current price of 0.3 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.25, and above the 200-day MA of 0.29, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 36.54 is Neutral, neither overbought nor oversold. The STOCH value of 13.79 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:EL8.

Elevate Uranium Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
AU$4.08B530.290.46%―――
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
61
Neutral
AU$797.89M-84.13-3.00%――-61.38%
46
Neutral
AU$140.03M-1.13-39.57%――-158.48%
45
Neutral
AU$99.03M-6.00-38.89%――2.23%
44
Neutral
AU$1.09B81.752.05%――85.14%
44
Neutral
AU$98.69M-8.15-17.73%――32.77%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:EL8
Elevate Uranium Ltd
0.21
-0.27
-56.25%
AU:PDN
Paladin Energy Ltd
9.07
0.46
5.34%
AU:AEE
Aura Energy
0.10
-0.15
-61.20%
AU:BMN
Bannerman Energy
3.34
-0.37
-9.97%
AU:DYL
Deep Yellow Limited
1.12
-0.89
-44.28%
AU:PEN
Peninsula Energy
0.25
-0.39
-61.66%

Elevate Uranium Ltd Corporate Events

Elevate Uranium Extends Deadline to Lift Marenica Stake to 90%
Sep 30, 2026
Elevate Uranium Ltd has granted a further extension to the closing date for acquiring the remaining 5% stake in Marenica Minerals, owner of the Marenica Uranium Project in Namibia, moving the deadline from 30 September 2026 to 30 October 2026. The...
Elevate Uranium Releases 2026 Annual Financial Report and Confirms Corporate Structure
Sep 25, 2026
Elevate Uranium Ltd has released its annual financial report for the year ended 30 June 2026, providing updated corporate information and confirming its current governance and administrative structure. The report underscores the company’s es...
Elevate Uranium Updates Director Murray Hill’s Equity Holdings
Sep 11, 2026
Elevate Uranium Limited has reported a change in the securities interests of director Murray Hill, reflecting adjustments in both his direct and indirect holdings through personal accounts and a family superannuation fund. The update details modif...
Elevate Uranium Clears Trading of New Employee Incentive Shares
Sep 11, 2026
Elevate Uranium Ltd has issued 910,890 fully paid ordinary shares following the conversion of an equivalent number of 2025 short-term employee incentive rights, expanding its share capital through equity-based staff compensation.The company has lo...
Elevate Uranium Seeks ASX Quotation for Additional Shares
Sep 11, 2026
Elevate Uranium Ltd has applied to the ASX for quotation of 910,890 ordinary fully paid shares. The new securities result from the exercise or conversion of existing options or other convertible instruments, modestly increasing the company’s...
Elevate Uranium Builds Critical Mass With 181Mlb Global Resource Base
Sep 8, 2026
Elevate Uranium Ltd is a uranium exploration and development specialist listed on the ASX, OTCQX and NSX, building a dedicated portfolio in two Tier-1 jurisdictions. The company is leveraging its proprietary U-pgrade processing technology to advan...
Elevate Uranium Options Lapse Without Exercise, Simplifying Capital Structure
Sep 2, 2026
Elevate Uranium Ltd has notified the market of the cessation of certain listed options after they reached their expiry date without being exercised or converted. The company reported that 300,000 Class B options and 100,000 Class A options, each w...
Elevate Uranium Reports Expiry of Unlisted Options
Sep 2, 2026
Elevate Uranium Ltd has announced that 100,000 Class EL8AN unlisted options and 300,000 Class EL8AO unlisted options, each exercisable at $0.70, expired on 28 August 2026. This expiry slightly reduces the company’s potential future share dil...
Elevate Uranium’s U-pgrade Pilot Plant Delivers Strong Early Results at Marenica
Aug 30, 2026
Elevate Uranium has reported successful interim results from its U-pgrade pilot plant in Namibia, which is treating ore from the Marenica Uranium Project. The first four stages of the five-stage process are operating to design, with ongoing optimi...
Elevate Uranium Delays Final Tranche in Marenica Share Purchase
Aug 7, 2026
Elevate Uranium has updated the market on its proposed issue of securities linked to the staged acquisition of shares in Marenica Minerals Pty Ltd. The company confirmed that settlement of the remaining 5% interest in Marenica has had its closing ...
Elevate Uranium Extends Deadline to Lift Marenica Project Stake to 90%
Aug 7, 2026
Elevate Uranium has extended the deadline to 30 September 2026 to complete the acquisition of a remaining 5% stake in Marenica Minerals, which owns the Marenica Uranium Project in Namibia. The company recently closed a separate deal to lift its ho...
Elevate Uranium Lifts Marenica Stake to 90% and Issues Cleansing Notice
Jul 29, 2026
Elevate Uranium Ltd has issued 4,701,659 fully paid ordinary shares as part of the consideration to acquire an additional 10% stake in Marenica Minerals, the owner of the Marenica Uranium Project in Namibia. This transaction increases Elevate Uran...
Elevate Uranium lifts Marenica stake as pilot plant optimisation continues
Jul 28, 2026
Elevate Uranium reported ongoing optimisation of its U-pgradeTM pilot plant in Namibia, where an expanded technical team is working to refine processing units and establish consistent baseline operations. The company warned that pilot plant result...
Elevate Uranium Extends Settlement Timeline for Marenica Share Purchase
Jul 28, 2026
Elevate Uranium Ltd has updated its disclosure on a proposed issue of securities linked to its acquisition of a further 5 percent stake in Marenica Minerals Pty Ltd. The company has notified the ASX that the closing date for settlement of this rem...
Elevate Uranium Seeks ASX Quotation for 4.7 Million New Shares
Jul 28, 2026
Elevate Uranium Ltd has applied to the ASX for quotation of 4,701,659 new ordinary fully paid shares, which were issued on July 28, 2026. The additional securities, linked to a previously announced transaction, will expand the company’s list...
Elevate Uranium lifts Marenica stake to 90% as Namibia portfolio grows
Jul 28, 2026
Elevate Uranium has increased its ownership of the Marenica Uranium Project in Namibia to 90 percent through two transactions, issuing 4,701,659 shares and paying $1.1 million in cash to acquire an additional 10 percent stake, while extending the ...
Elevate Uranium Plans New Share Issue to Strengthen Capital Base
Jul 12, 2026
Elevate Uranium Ltd has lodged a notice with the ASX outlining a proposed issue of up to 9,333,900 ordinary fully paid shares under a placement or similar capital-raising structure. The new securities, expected to be issued on 31 July 2026, will b...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 26, 2026